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http://dx.doi.org/10.1016/j.bbamem.2013.07.001a b s t r a c ta r t i c l e i n f oAvailable online 4 July 2013 The turn of the millennium coincided with the branding of a fundamentally different class of enzyme - proteases
that reside immersed inside the membrane. This new ﬁeld was the convergence of completely separate lines of
research focused on cholesterol homeostasis, Alzheimer's disease, and developmental genetics. None intended
their ultimate path, but soon became a richly-integrated fabric for an entirely new ﬁeld: regulated intramembrane
proteolysis. Our aim in this Special Issue is to focus on the ancient and nearly ubiquitous enzymes that catalyze this
unexpected yet important reaction. The pace of progress has been dramatic, resulting in a rapidly-expanding uni-
verse of known cellular functions, and a paradigm shift in the biochemical understanding of these once heretical
enzymes. More recently, the ﬁrst therapeutic successes have been attained by targeting an intramembrane prote-
ase. We consider these advances and identify oncoming opportunities in four parts: growing spectra of cellular
roles, insights into biochemical mechanisms, therapeutic strategies, and newly-emerging topics. Recent studies
also expose challenges for the future, including non-linear relationships between substrate identiﬁcation and
physiological functions, and the need for potent and speciﬁc, not broad-class, inhibitors.
© 2013 Published by Elsevier B.V.1. Introduction
1.1. Unexpected beginnings
Intramembrane proteases were discovered through studies that
had vastly different starting points, ranging from Alzheimer's disease
etiology [1], to cholesterol biosynthesis [2], and embryogenesis [3].
The only common guiding principle was the appreciation that protein
domains can be shed from the membrane as a regulatory mechanism,
and in some cases these events were central to diseases. The goal was
to understand the molecular players and reactionmechanisms under-
lying biology and disease [4].
One instructive example is the amyloid-β precursor protein (APP), a
large, single-passmembrane protein fromwhich an internal 42-residue
peptide was found in the senile plaques of Alzheimer's patients
[11,19,18]. The C-terminus of Aβ42 resided within the APP trans-
membrane segment, but it was assumed that proteolysis followed
membrane breach. It was only cloning of the early-onset Alzheimer's
disease gene presenilin, and subsequent biochemical detective-work
with its 9 transmembrane integral membrane protein product, that
began to raise the possibility of this proteolysis occurring naturally
within the membrane by a novel aspartyl protease [1]. Two years
earlier the site-2 protease (S2P) intramembrane metalloenzyme was
cloned as the activity that liberates cholesterol-activating transcription
factors by cleaving transmembrane segments [2]. Then, 2 years later,re, Maryland, 21205, USA.
b);
sevier B.V.the key developmental signaling factor rhomboid was identiﬁed to be
an intramembrane serine protease [3]. Today these three superfamilies
of intramembrane proteases are known to catalyze these unusual reac-
tions (Fig. 1), although others may still await discovery.
What could not have been predicted was the widespread nature of
the enzymes that were uncovered by these focused studies, and
the broad biology that they govern. Intramembrane proteases are
present from archaea to plants and animals, and are among the
most widely-distributed membrane proteins in all life forms [5–7].
Since these seminal beginnings, the pace of progress has been rapid
in three areas: deﬁning cellular roles, elucidating biochemical mecha-
nisms, and designing therapeutic strategies. Research on each of
the three enzyme families lies at different points along this pathway,
and experience both common and unique challenges. This Special
Issue collates the current progress and explores future opportunities
of this burgeoning ﬁeld of biochemistry.
2. Part I: Cellular functions
The ﬁrst intramembrane protease to be discovered was site-2
protease, a metalloenzyme that regulates cholesterol/fatty acid syn-
thesis and stress responses [2]. Fittingly Rawson begins our Special
Issue by describing the historic discovery of this central enzyme,
which, as a rule, plays essential functions in metazoans [9]. However,
Rawson also details recent exceptions to this rule, highlighting
discovery of X-linked hypomorphic mutations in S2P that lead to
human congenital skin and neurological pathologies, and an unexpect-
ed caspase-dependent cleavage mechanism that renders ﬂies null for
S2P entirely viable.
Rhomboid Site-2 Presenilins/ -Secretase
Proteases Proteases                      Signal Peptide Peptidases 
(serine proteases)                 (metalloproteases) (aspartyl proteases)      
cytoplasm 
Fig. 1. The three known families of intramembrane proteases. X-ray crystal structure models for each intramembrane protease family prototype are diagrammed in a membrane
bilayer. The intramembrane catalytic residues are shown in yellow stick format emanating from transmembrane cylinders, while the catalytic zinc is depicted in green. The pro-
karyotic enzymes are Escherichia coli rhomboid GlpG (PDB ID: 2NRF); Methanocaldococcus jannaschii site-2 protease MJ0392 (PDB ID: 3B4R), and the Methanoculleus marisnigri
presenilin JR1 (PDB ID: 4HYD). These bacterial and archaeal enzymes are serving as structural prototypes for understanding intramembrane protease mechanisms.
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versatile circuits that trigger a wide spectrum of pathways, ranging
from stress responses to virulence gene expression [10]. In most, but
not all, cases the cleavage ultimately frees a transcription factor domain
to activate target gene expression. Schneider and Glickman discuss
this classical yet broad function, adding two new categories for the
currently-known functions of S2Ps in various bacteria.
One of the most pursued, yet evasive, enzyme targets has been
γ-secretase (the presenilin holoenzyme complex). The reason for this
discrepancy is the multifaceted biology underlying its function [11].
By integrating studies from human genetics and mouse models,
Jurisch-Yaksi et al. provide a comprehensive overview of the
expanding biological roles that γ-secretase plays in vertebrate animals.
This functional spectrum illustrates both the challenges, and opportuni-
ties, in therapeutic intervention against γ-secretase.
Long considered to be “orphan cousins” of γ-secretase, Fluhrer
and colleagues describe how signal peptide peptidases (SPPs) are
rapidly emerging as key regulators of various speciﬁc functions in eu-
karyotes, particularly in the vertebrate immune system [12]. SPP-like
(SPPL) proteases reside in a variety of organelles, albeit not in the nucleus
or mitochondria/plastids (perhaps because bacteria lack aspartyl
intramembrane proteases). SPP was discovered as the activity that
cuts signal peptides [7], but some of the resulting fragments have
post-targeting functions in immune surveillance. SPPL2a/b, in contrast,
are present only in vertebrates where they reside outside the ER and
cleave signaling molecules that organize immune system function.
Studies in small model organisms also hint at developmental functions
for SPP during embryogenesis, although speciﬁc functions remain to be
worked out.
Rhomboid proteases were the last superfamily to be discovered
as intramembrane proteases [3]. Although central to cell signaling in
Drosophila development, the functions of rhomboid proteins in
mammals, which served as the subjects for discovery of the other two
intramembrane protease families, has remained mysterious [13].
Bergbold and Lemberg now review new discoveries that are starting
to shed light on rhomboid function in mammals. Particularly intrigu-
ing is the discovery of inactive rhomboid proteins that lack protease
activity but regulate the trafﬁcking and quality control of other
membrane proteins. Unexpected links to diseases are also starting
to emerge, although it is too early to know the extent to which
rhomboid proteins are involved.
In contrast to the progress with vertebrate rhomboid proteins,
the function of rhomboid proteases in bacteria remain limited [14],
even despite increasingly deep understanding of their biochemical
mechanisms and structures. Rather considers the current state of prog-
ress with prokaryotic organisms, and highlights new approaches based
on more sophisticated bioinformatic co-segregation analysis, whichtracks the genomic co-occurrence of rhomboid proteins with other
membrane proteins throughout evolution, as a new means to identify
important substrates. Although promising, these targets are yet to be
validated.
A central theme to emerge from studying all eukaryotic intra-
membrane proteases is the importance of subcellular trafﬁcking to
regulating proteolysis [15]. Morohashi and Tomita explore how sub-
cellular trafﬁc determines the ultimate outcome of these key proteolyt-
ic events, from whether and when the protease and substrate meet, to
the different outcomes that depend on where the cleavage takes place
in a cell.
Clearly studies over the past few years have emphasized how fre-
quently intramembrane proteases are being found at the nexus of
key biological processes. Given the fact that the majority of intra-
membrane proteases functions remain a mystery, the ﬁeld is poised
for many new and exciting discoveries.
3. Part II: Biochemical mechanisms
Although even early data implied that hydrolysis of peptide bonds
was being catalyzed within the cell membrane by unusual, integral
membrane enzymes, the uncomfortable conceptual problemwas the be-
lief that themembrane, being awater-excluding environment, should be
unable to support hydrolysis [1–3].
What had been missing for all three enzyme candidates is the
biochemical standard of proof that the isolated polypeptides, in
pure form in vitro, could catalyze the hydrolysis of peptide bonds.
Over the past decade this challenge has been overcome, and pure
enzyme systems are now routine for all three families of intra-
membrane proteases, albeit not necessarily for every individual
member of interest.
Yet evenwith these powerful tools in hand, deciphering the enzy-
matic mechanism in detail can only be realizedwith a solid structural
foundation. Although this is the common bottleneck with mem-
brane proteins, intensive efforts were rewarded unexpectedly early
(Fig. 1).
Brooks and Lemieux discuss the ﬁrst high-resolution structures to be
solved of bacterial rhomboid proteases [16]. Subsequentwork has started
to integrate enzymatic analysis, application of biophysical methods, and
further structures solved under various conditions. Although a more de-
tailed model of intramembrane proteolysis is starting to emerge, many
key gaps nevertheless remain and are highlighted.
Kroos and Akiyama continue this theme with S2Ps, which pose a
greater challenge to structural analysis; to date the structure of only
one S2P ortholog has been solved [17]. Since S2Ps cleave only sub-
strates that have had their ectodomain removed by site-1 cleavage,
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have also been studied structurally. Kroos and Akiyama translate the
wealth of molecular genetic and biochemical data with available struc-
tural models, yielding new predictions that could drive future explora-
tion into S2P mechanism.
A major landmark has been achieved in the past few months (see
Ref. [18]); the ﬁrst structure of a true presenilin-family protease has
been solved to high resolution (Fig. 1). Wolfe describes how the
archaeal presenilin prototype serves as a critical ﬁrst blueprint for
decoding the mechanism of these important but enigmatic enzymes.
Yet even before a structural framework became available, the progress
on presenilin mechanism using detailed biochemical interrogation has
been impressive, yielding new and unexpected enzymatic insights in-
cluding two separate but processive pathways for generating a wide
spectrum of products.
Collectively these structural achievements have unveiled the ﬁrst
molecular snapshots of all three intramembrane protease families, and
proof that their catalytic residues are indeed immersed within the
plane of themembrane, as predicted (Fig. 1 in yellow). They also reveal
the active sites to be hydrated and suggest howwatermight gain entry,
but what remains woefully missing is detailed information on sub-
strate–enzyme interactions along the cleavage reaction.
4. Part III: Therapeutic strategies
The maturity of a ﬁeld is often measured by its ability to convert
the depth of accumulated knowledge to the beneﬁt of mankind.
While it is clear that research on many intramembrane proteases is
rapidly moving in this direction, achieving this ultimate goal requires
a thorough and integrated understanding of both the cellular func-
tions and biochemical mechanisms. Yet even despite their obvious
complexity, it is exciting that the ﬁrst clinical successes have recently
been attained for an intramembrane protease, with additional promis-
ing strategies already appearing on the horizon.
γ-Secretase was ﬁrst identiﬁed as a protease implicated in
Alzheimer's disease and immediately became a target for designing
protease inhibitors [19]. However, inhibition led to severe toxicity
due to blocking the processing of other substrates, especially the
Notch receptor. As described by Golde and colleagues, further invest-
ment in biochemical research resulted in the identiﬁcation of drugs
that allowed processing but shifted the cleavage site in APP. This sim-
ple observation raised hope that not inhibition, but modulation of this
essential protease activity could be turned to therapeutic advantage,
which is currently undergoing clinical trials. Nevertheless the in-
vestment and hard work into γ-secretase is beginning to pay off in
an unexpected realm: three anti- γ-secretase drugs have recently
entered the clinic as treatments for a variety of cancers including
pancreatic cancer. This repurposing underscores the importance
of thorough basic research for identifying unintended therapeutic
opportunities.
Two further examples set the stage for future therapeutic interven-
tions (with many more examples on the way), although work remains
before even the ﬁrst rigorous tests can be attempted.
Some of the greatest global health and economic challenges today are
inﬂicted by protozoan parasites [20]. The diversity of these organisms is
staggering, yet Sibley argues that intramembrane proteases are emerging
as possible common targets for multiple diseases. Essential functions
have been identiﬁed for both rhomboid proteases and SPP in the malaria
parasite, as well as rhomboid proteases in other unrelated parasites.
These observations raise the exciting possibility of being able to target a
diverse array of parasitic diseases with a single enzyme target, although
compounds of sufﬁcient potency and speciﬁcity have yet to be
demonstrated.
Looking deeper into the future, Chen and McQuibban describe the
ascent of the mitochondrial rhomboid protease PARL into one of themost studied – and promising – avenues into the therapeutic realm
[21]. Several independent lines of study in type 2 diabetes and
Parkinson's disease have converged on PARL. In fact, recently even
mutations in PARL itself have been found in patients with both ill-
nesses, although it is not yet clear whether the mutations play a
role in disease.
Chen and McQuibban argue that PARL may be a master regulator of
mitochondrial stress responses through interplay of regulating apoptosis,
mitophagy and organelle morphology. Since PARL appears to play differ-
ent functions in healthy versus damaged mitochondria, therapeutic op-
portunities may exist. The challenge lies in deciphering the complex
regulatory network surrounding PARL that involves phosphorylation/
dephosphorylation, proteolysis, mitochondrial-nuclear signaling,
and at least three distinct substrates. Although these are early times for
PARL research, as argued by Chen andMcQuibban the therapeutic prom-
ise of this complex “gate-keeper” enzyme should not be under-estimated.
5. Part IV: Emerging topics
We conclude our Special Issue by considering a few emerging
topics: two areas of biology where the prominence of RIP has been
slower to emerge are virology and plant biology. Ye provides a collec-
tion of new roles that S2Ps and SPPs play in virus infection on the one
hand, and the antiviral host response on the other [22]. Only rhom-
boid proteases seem devoid of functions in these virus combat
zones, although absence of evidence should not be taken as evidence
of absence.
In contrast, the genomes that encode by far the greatest number of
intramembrane proteases are those of plants, yet only recently have
concerted efforts yielded the ﬁrst insights [23]. In fact, perhaps the
clearest progress has been in chloroplasts, which contain both S2P
and rhomboid proteases (in contrast tomitochondria,which apparently
lost S2P). Adam argues that chloroplasts act as a nexus in which organ-
elle morphogenesis, chloroplast-nuclear communication, and develop-
mental signaling are intricately controlled by S2P and rhomboid
intramembrane proteases. Further research with plants is likely to
provide enormously fertile ground, since 10% of plant transcription fac-
tors are membrane-anchored and plants encode a vast arsenal of
intramembrane proteases.
Finally, Kinch and Grishin take us back to the beginning by
reconsidering rhomboid protease evolution [24]. Intramembrane
proteases are nearly ubiquitous enzymes across all life forms, pre-
senting a wealth of biological settings for analysis, yet complicating
evolutionary interpretations. Kinch and Grishin use network-based
clustering to present a provocative view of rhomboid protease evolution,
which thus far has been studied the most extensively of any
intramembrane protease. They suggest that the last universal com-
mon ancestor already had developed two rhomboid proteases —
the second being PARL-like. Applying similar clustering analyses to
other intramembrane proteases could help determine which themes
might be common, versus different, in intramembrane protease evo-
lution.
6. What lies ahead?
Clearly tremendous strides have already been made in understand-
ing intramembrane proteases, and the pace of progress is accelerating.
So much so, in fact, that a dedicated Gordon Research Conference has
recently been established to maintain dialogue among an increasingly
multidisciplinary and international ﬁeld (“Regulated Proteolysis of
Cell Surface Proteins,”March 30–April 4, 2014, Venture, CA).
Looking forward, a different area stands out for each intra-
membrane protease family as exciting opportunities for immediate
investment. For rhomboid proteases, a key challenge lies in ﬁnding
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rather than compiling lists of “bystander” proteins whose cleavage oc-
curs physiologically, but is inconsequential for the cell. In that light, cur-
rent proteomic and bioinformatics methods are only starting to offer
resources for such novel membrane enzymes [8]. Despite the advan-
tages of using inhibitors to glean deeper physiological and biochemi-
cal insights with potential for therapeutic opportunities, not a single
inhibitor has yet been developed for any S2P. In contrast, γ-secretase
has been the subject of intense research into both its substrate reper-
toire and inhibitor development. However, its biochemical mechanism
is far more complex than that of rhomboid or S2P. Since the ﬁrst
high-resolution structure of a true presenilin homolog has only recently
been attained, the enormous task of interrogating γ-secretase mecha-
nism through this new lens is only now beginning.
Investing effort into these three important, albeit challenging,
technical areas is likely to accelerate progress even further, making
for a truly exciting journey ahead.
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